Chorea
Information
- Disease name
- Chorea
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00950196 | Completed | Phase 4 | Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia | November 2008 | November 2009 |
| NCT00271596 | Completed | Phase 2 | Citalopram to Enhance Cognition in HD | November 2005 | November 2011 |
| NCT00368849 | Completed | Phase 2 | Atomoxetine and Huntington's Disease | November 2005 | February 2008 |
| NCT00001930 | Completed | Phase 2 | Treatment of Huntington's Chorea With Amantadine | April 1999 | February 2001 |
| NCT04201834 | Completed | Phase 2 | Risperidone for the Treatment of Huntington's Disease Involuntary Movements | August 13, 2020 | December 30, 2023 |
| NCT01795859 | Completed | Phase 3 | First Time Use of SD-809 in Huntington Disease | August 5, 2013 | December 5, 2014 |
| NCT01019473 | Terminated | Phase 2 | Efficacy, Safety and Tolerability of AFQ056 in Patients With Huntington's Disease in Reducing Chorea | November 2009 |
- HPO alt_id (Human Phenotype Ontology)
- HP:0002397
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002072
- MeSH unique ID (MeSH (Medical Subject Headings))
- D002819